22% Upside - Agios Pharmaceuticals Agio - Airbus Eadsy - Altagas Atgff - Amazon Amzn - Anglo American Aaukf Aauky - Big Lots Big - Biomarin Pharmaceutical BMRN - Blackrock Muni New York Intermediate Duration Fund - Blackrock Muniholdings New York Quality Fund - Blackrock Muniyield - Blackrock New York Municipal Quality Trust - Boeing Ba - Bristol-Myers Squibb Bmy - Carl Zeiss Meditec AG - Celyad Cyad - Champions League - Chewy's Chwy - Chief Operating Officer Stuart Haselden - Clayton Dubilier - Conn's Inc - Credit Suisse - Cumulative Preferred Shares - Discover Dysplasias - Dividend Growth Stocks Model Portfolio - Eagle Pharmaceuticals Egrx - Exxon Mobil Xom - Fda Oks - Germany Amzn - Healthpeak's Britannia Oyster Point - Hna Group - Hna's SR Technics - Hologic's Holx - Hudson Pacific Properties - JLL Income Property Trust - Jpmorgan & Chase Company - Kalvista Pharmaceuticals Kalv) -18% after KVD001 - L3harris LHX - Morgan Stanley - Netflix NFLX - Nkg2d-Based Car-T - Payable Dec - Payable Jan - Penn National Gaming - Popular Inc Bpop - Qutoutiao QTT - Raging Capital Management - Regeneron Pharmaceuticals Regn - Ryanodex Nda - Sanofi Sny - Seeking Alpha - Softbank Vision Fund SFTBF - Tesla Tsla - Underperform Analyst Vivek Arya - Ups Ups - Vail Resorts MTN - Via Its Acquisition of Celgene - Wall Street Breakfast - Wolfpack Research Wolfpack - [[aaukf]], [[aauky]] - [[blue]] +3% - [[bmy]] +05% - [[bpop]] +16% - [[egrx]] +52% - [[ups]] +03% - [[xom]] -03%